Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
0.960
+0.033 (3.58%)
At close: Mar 11, 2025, 4:00 PM
0.940
-0.020 (-2.08%)
After-hours: Mar 11, 2025, 6:55 PM EST
Fate Therapeutics Employees
Fate Therapeutics had 181 employees as of December 31, 2023. The number of employees decreased by 370 or -67.15% compared to the previous year.
Employees
181
Change (1Y)
-370
Growth (1Y)
-67.15%
Revenue / Employee
$75,309
Profits / Employee
-$1,029,072
Market Cap
110.01M
Employees Chart
FATE News
- 6 days ago - Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 7 days ago - Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 25 days ago - Fate Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Fate Therapeutics Has Promising Off-The-Shelf Cell Therapies While Looking Cheap - Seeking Alpha
- 5 weeks ago - Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus - GlobeNewsWire
- 3 months ago - Fate Therapeutics Announces Leadership Transition - GlobeNewsWire
- 3 months ago - Fate Therapeutics to Present at Upcoming December Investor Conferences - GlobeNewsWire